Vectura Group PLC | Mutual Funds
Mutual Funds that own Vectura Group PLC
HBM BioVentures Ltd.
67,136,351
10.09%
870,892
4.74%
12/31/2017
M&G Investment Funds (7) OEIC - European Strategic Value Fund
23,565,000
3.54%
837,333
0.72%
03/29/2018
Neptune Investment Funds - UK Mid Cap Fund
22,437,713
3.37%
11,579,920
3.97%
06/30/2017
Aberforth Smaller Companies Trust Plc
18,049,450
2.71%
83,200
1.03%
08/31/2018
Invesco Perpetual UK Invt. Ser. - UK Growth
15,297,879
2.29%
1,525,022
1.07%
03/29/2018
Fidelity Invt. Funds - Special Situations Fund
14,558,178
2.19%
0
0.35%
12/31/2017
Government Pension Fund - Global (The)
14,255,016
2.14%
-4,376,324
0%
12/31/2017
Oddo Avenir Europe
10,144,733
1.53%
-8,370
0.27%
04/30/2018
St. James's Place Unit Trust - Allshare Income
10,000,000
1.5%
0
0.83%
03/31/2018
River & Mercantile Funds ICVC - UK Equity Smaller Companies
10,000,000
1.5%
2,500,000
0.95%
09/30/2017
| Address |
1 Prospect West
Chippenham Wiltshire SN14 6FH
United Kingdom
|
|
Employees
|
- |
| Website |
http://vectura.com |
| Updated |
07/08/2019 |
| Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. It operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. |
